Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia. [electronic resource]
Producer: 20170629Description: 466-477 p. digitalISSN:- 1092-8529
- Administration, Oral
- Adult
- Antipsychotic Agents -- administration & dosage
- Aripiprazole -- therapeutic use
- Basal Ganglia Diseases -- chemically induced
- Benzodiazepines -- therapeutic use
- Delayed-Action Preparations
- Female
- Haloperidol -- therapeutic use
- Humans
- Hyperprolactinemia -- chemically induced
- Injections, Intramuscular
- Male
- Middle Aged
- Olanzapine
- Paliperidone Palmitate -- administration & dosage
- Perphenazine -- therapeutic use
- Proportional Hazards Models
- Quetiapine Fumarate -- therapeutic use
- Risperidone -- therapeutic use
- Schizophrenia -- drug therapy
- Schizophrenic Psychology
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.